Published :
Tables : 48
Figures : 42
Category : Healthcare
No. of Pages : 215
Report Code :
Transdermal drug delivery system market is expected to reach a CAGR of 4% over the forecast period 2022-2028. The growth of this market has been determined by assessing the increase in the prevalence of chronic diseases and technological advancements in transdermal drug delivery systems. The growing levels of persistent diseases have meant that there has been a boost in the biotechnology and pharmaceuticals sectors. This, in turn, has allowed for exponential growth in the market worldwide. There are several applications within these systems which are useful in various ailments ranging from hormonal disorders to pain management and cardiovascular diseases. These are all factors which will see a boost in growth opportunities for the transdermal drug in upcoming years. These significantly reduced pain in patients, non-invasiveness is what is helping to keep the market afloat. Thus, drug delivery systems contain many disadvantages such as irritation of the edema, which may restrain the global transdermal drug delivery system market growth. The market is divided based on type, end-user and application. The transdermal patches are further fragmented into drug-in-adhesive patches, microneedle patches matrix patches, reservoir membrane patches and. The transdermal semisolids will have sprays, gels and ointments. This study will include an outline of the drug chain industry as well as the industry environment, and then will assess the market size and finally, it's forecast. According to the applications, the market is shown to be fragmented by different segments such as hormonal disorders, along with other such ailments, smoking cessation and overactive bladder treatment. In the year 2020, the pain management segment is predicted to reach the largest of the transdermal drug delivery system and the transdermal patches segment is also expected to increase at a higher rate. Key players included in the Transdermal Drug Delivery System Market are: Hisamitsu Pharmaceutical, Mylan, UCB, Novartis, GlaxoSmithKline, Boehringer Ingelheim, Johnson & Johnson, Endo International, and Purdue Pharma. Competitive Landscape: There are rising levels of diseases such as that of chronic pain, cardiovascular diseases, central nervous systems disorders. Seeing how common these diseases are, has resulted in the increased use of contraceptives and has allowed for further research into the market of transdermal drug delivery systems. Transdermal drug delivery systems market has been identified as a profitable target market. This has resulted in there being many international players, such as Mylan, who manufacture high quality innovative transdermal drug delivery systems, such as adhesive patches. Transdermal Drug Delivery System Segmentation: By Type Transdermal Patches Transdermal Semisolids By Application Pain Management Hormonal Applications Central Nervous System Disorders Cardiovascular Diseases Other Applications By End User Hospitals & Cardiac Centers Ambulatory Surgery Centers By Region North America Europe Asia Pacific Latin America Middle East and Africa FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide an exhaustive analysis on global transdermal drug delivery system market by type, by application, by end user and by region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies To evaluate and forecast micro-markets and the overall market Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The growth of this market has been determined by assessing the increase in the prevalence of chronic diseases and technological advancements in transdermal drug delivery systems.
The growing levels of persistent diseases have meant that there has been a boost in the biotechnology and pharmaceuticals sectors. This, in turn, has allowed for exponential growth in the market worldwide. There are several applications within these systems which are useful in various ailments ranging from hormonal disorders to pain management and cardiovascular diseases. These are all factors which will see a boost in growth opportunities for the transdermal drug in upcoming years. These significantly reduced pain in patients, non-invasiveness is what is helping to keep the market afloat. Thus, drug delivery systems contain many disadvantages such as irritation of the edema, which may restrain the global transdermal drug delivery system market growth.
The market is divided based on type, end-user and application. The transdermal patches are further fragmented into drug-in-adhesive patches, microneedle patches matrix patches, reservoir membrane patches and. The transdermal semisolids will have sprays, gels and ointments.
This study will include an outline of the drug chain industry as well as the industry environment, and then will assess the market size and finally, it's forecast.
According to the applications, the market is shown to be fragmented by different segments such as hormonal disorders, along with other such ailments, smoking cessation and overactive bladder treatment. In the year 2020, the pain management segment is predicted to reach the largest of the transdermal drug delivery system and the transdermal patches segment is also expected to increase at a higher rate.
Key players included in the Transdermal Drug Delivery System Market are:
Hisamitsu Pharmaceutical, Mylan, UCB, Novartis, GlaxoSmithKline, Boehringer Ingelheim, Johnson & Johnson, Endo International, and Purdue Pharma.
Competitive Landscape:
Transdermal Drug Delivery System Segmentation:
By Type
By Application
By End User
By Region
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Transdermal Drug Delivery System Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Transdermal Drug Delivery System Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Transdermal Drug Delivery System Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Transdermal Drug Delivery System Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Transdermal Drug Delivery System Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Transdermal Patches 7.2. Transdermal Semisolids 8. Transdermal Drug Delivery System Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Pain Management 8.2. Hormonal Applications 8.3. Central Nervous System Disorders 8.4. Cardiovascular Diseases 8.5. Other Applications 9. Transdermal Drug Delivery System Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospitals & Cardiac Centers 9.2. Ambulatory Surgery Centers 10. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. Hisamitsu Pharmaceutical 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Mylan 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. UCB 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Novartis 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 GlaxoSmithKline 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Boehringer Ingelheim 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Johnson & Johnson 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Endo International 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Purdue Pharma 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics